Study Summary
This trial will test if treating ovarian cancer with Heated Intraperitoneal Chemotherapy (HIPEC) followed by intravenous (IV) chemotherapy can start within 42 days of HIPEC.
- Ovarian Cancer
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 7 Secondary · Reporting Duration: Up to 2 years
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
1 Treatment Group
HIPEC + adjuvant IV chemotherapy
1 of 1
Experimental Treatment
20 Total Participants · 1 Treatment Group
Primary Treatment: HIPEC · No Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · Female Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is the enrollment period for this research study currently accessible to participants?
"As of today, this medical study is still recruiting participants. It was initially published on December 15th 2017 and the latest update to its page occurred on January 21st 2022." - Anonymous Online Contributor
How many individuals are being enrolled in this clinical experiment?
"Correct, according to records on clinicaltrials.gov this study is actively recruiting participants. It was first posted in December 2017 and most recently updated in January 2022 with the aim of enrolling 20 people at one site." - Anonymous Online Contributor
Has the use of HIPEC been examined in other research efforts?
"Presently, 1174 investigations into HIPEC are underway with 332 in their final phase. Of these trials, the majority originate from Shanghai; however, there exist 66513 different sites where such studies may be conducted." - Anonymous Online Contributor
Has the FDA given clearance to use HIPEC?
"HIPEC's safety has been largely corroborated in Phase 2 clinical trials, so it was rated a 2." - Anonymous Online Contributor